Outcome Capital hosted an expert panel and networking event around facilitating M&A transactions in the MedTech Services sector last week.

Outcome Capital is a highly specialized life sciences and healthcare advisory and investment banking firm, providing innovative companies with a value-added, market-aligned approach to mergers & acquisitions, partnering and corporate finance. The firm leverages its proven ‘strategy-led execution’ approach to value enhancement by assisting management teams and their boards in navigating both financial and corporate markets and implementing the best path for success. The firm’s strength stems from its multi-disciplinary, industry experts who draw from their broad relationships and a wide range of scientific, operational, strategic and transactional expertise across the value chain. Comprised of former CEOs, business development executives, venture capitalists, PhD/MD-level scientists and clinicians, and experienced commercialization experts, our team is driven to propel innovation from bench to bedside. Outcome Capital is proud of its unique culture of intellectual agility and openness, data-driven perspectives, strategic thinking, and commitment to teamwork. We are devoted to providing unmatched advisory services to our clients and share an uncompromised dedication to the life sciences and healthcare industry success. The Outcome Capital Difference - - Creating Extraordinary Outcomes. Maximizing your company’s value by bringing… - Unique Insights - In-depth Industry Experience & Networks - Personal Commitment to Clients - Exceptional Record of Success Outcome provides comprehensive strategic advisory and investment banking services in the following areas: Life Sciences - Pharma - Medical Devices - Biotech - Healthcare Services - Diagnostics - Tools and Research - Pharma services - Digital health

Founded 1998